November 05, 2018
3 min watch
Save
This article is more than 5 years old. Information may no longer be current.
VIDEO: Presenter discusses trials to evaluate safety, efficacy of ALLN-177 for hyperoxaluria
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
SAN DIEGO — At ASN Kidney Week 2018, Annamaria T. Kausz, MD, MS, discussed two phase III trials that evaluated the safety and efficacy of ALLN-177 in patients with enteric hyperoxaluria.